For the latest news and information about the coronavirus pandemic, visit the World Health Organization and Centers for Disease Control and Prevention websites.
there is newSurprisingly, it is not And Or any pharmaceutical company. The US Army has announced early results for a vaccine developed by the Walter Reed Military Research Institute that includes defense against the now-common — strain In people who have received two or more vaccinations.
Vaccines have proven highly effective in preventing serious illness and death from COVID-19. Recent data released Jan. 5 from Washington state shows that people over 65 are 13 times more likely to be hospitalized and 15 times more likely to die from COVID-19 than those over 65 who Receive two doses of Moderna or Pfizer vaccines or one dose of Johnson & Johnson.
With the outbreak of variable omicron around the world and outbreaks among“Leave governments and medical experts scramble, an effective military vaccine for current and future COVID-19 variants could become a solution to changing the pandemic to stop reinfection from coronavirus mutations.
The military is not only preparing to confront COVID-19. Scientists are designing the vaccine to be adaptable to all viruses in the coronavirus family, both future and past, including SARS, a virus that infected more than 8,000 people during its last outbreak in 2003.
We’ll share what we know about the COVID-19 vaccine for the military, including how it works and when it could become available. Here is the current running statusWhat do we know about him? And Putting people at risk today.
The three vaccines now authorized for use in the United States take two ways to protect against COVID-19 infection. Use of Pfizer and Moderna vaccinesTo build immunity against disease, the Johnson & Johnson vaccine uses a harmless virus (not the virus that causes COVID-19) to train the body’s immune system to respond to COVID.
The US military’s vaccine — officially called the COVID-19 Spike Ferritin Nanoparticle Vaccine (or SpFN) — takes a third approach, using a harmless portion of the COVID-19 virus to catalyze the body’s protection against COVID.
The Army vaccine also has less restrictive storage and handling requirements than Moderna and Pfizer’s vaccines, allowing it to be used in a variety of situations. The Army vaccine can be stored in a refrigerator between 36 degrees Fahrenheit and 46 degrees Fahrenheit for up to six months and at room temperature for up to one month, according to military scientists. Pfizer’s vaccine requires very cold freezer (between 130°F and -76°F) for shipping and storage and is stable for 31 days when stored in the refrigerator.
The vaccine was tested in two doses, 28 days apart, and also with a third injection 6 months later.
Vaccines from Moderna, Pfizer and Johnson & Johnson all target a specific virus — SARS-CoV-2 — that causes COVID-19. Army scientists are expanding and designing their vaccine to be a “global coronavirus,” meaning they plan to use it against a variety of coronaviruses, including new strains of the virus as they emerge.
Dr Kavon Mudgharad, founding director of the Emerging Infectious Diseases Branch at Walter Reed Army Research Institute, told the Army Times, “We have designed this platform and made it a next-generation vaccine, which paves the way for a universal vaccine to protect not only the current virus, but also to confront the changing future, and stopping it in its tracks before it causes another pandemic.”
Although the Army vaccine has not been directly tested on the omicron variant, scientists working on the vaccine said its protection showed promising results against omicron in the lab using samples from human trials.
No date has been set. The vaccine is now undergoing clinical trials to determine its safety and efficacy. Normally, it could take three to five years to complete all three phases of a clinical trial, but the urgency of the COVID-19 pandemic could speed up the process. Current FDA-approved COVID vaccines have been tested, reviewed and approved within one year.
After data from the first phase of human trials are collected, analyzed and formally published, the phase two and phase three trials will begin. There is very little information yet about when or how these trials will take place or whether the stages will overlap.
To follow the progress of Army vaccine trials, visit the SpFN COVID-19 vaccine tracker provided by the US Army Medical Research and Development Command.
For more information on COVID-19, here’s what we know about how the CDC defines it., how , And after two years.
The information in this article is for educational and informational purposes only and is not intended to provide health or medical advice. Always consult a physician or other qualified healthcare provider with any questions you may have about a medical condition or health goals.